SANDOVAL DAVID I. (General Counsel) sold 9.7% of their position (4.47K shares) of MAXCYTE, INC. on the open market
Open‑market sale worth $20.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/14/2025ACC: 0000905148-25-000092
Officer· General Counsel
Since Feb 2024
-4.47K
Net shares
Net seller
$20.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.47K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.47K
Price / share
$4.54
Trade value
$20.27K
% of position
9.7%
1/13/2025
45.91K→41.45K
Total
Net shares
−4.47K
Net value
-$20.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2025 | S · Sale | −4.47K | $4.54 | $20.27K | 9.7% | 45.91K | 41.45K |
| Total | −4.47K | -$20.27K | ||||||
Derivative Transactions0
No derivative transactions reported